Trial intelligence / Profile preview

Post-Marketing Study of Requip in Parkinson's Disease

NCT00485069Phase 4Completed

Sponsor
GSK
Start
Jun 2007
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ropinirole in Parkinson's disease (PD), sponsored by GSK. Started Jun 2007; status: completed.

02

Drugs

ropinirole
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT00485069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00485069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call